DR. ED ERGENZINGER
Ed is a seasoned patent attorney with more than 20 years of in-house and private practice experience. He has worked at AmLaw 50, AmLaw 100, and AmLaw 200 law firms as well as in-house as Director of IP & Legal Affairs for the Duke Human Vaccine Institute (DHVI) and as Chief Legal Officer and Senior VP of Innovation for a startup focused on enhanced delivery of cannabinoids. As virtual in-house counsel for Wyeth Vaccines, he managed the worldwide patent portfolio for Prevnar 13® and served as outside counsel for a Duke spin-out through its $96 Million acquisition by Illumina. Ed has authored and co-authored over 100 scientific and legal publications in journals including Nature Neuroscience and Nature Biotechnology, while teaching patent law at Wake Forest, UNC, and Campbell law schools. Prior to law school, he earned a doctorate in neuroscience as a National Institute of Mental Health Predoctoral Fellow at Wake Forest School of Medicine.
Bar Admissions & Court Admissions
+ United States Patent & Trademark Office
+ North Carolina Bar
+ United States Supreme Court
Practice Areas
+ Domestic and international patent applications
+ Global patent portfolio strategy and management
+ Intellectual property due diligence
+ IP opinions and counseling
+ IP-related agreements drafting and negotiation
Education & Training
+ Wake Forest University Graduate School (Ph.D., Neuroscience)
+ Wake Forest University School of Law (J.D., Law)
+ Wake Forest University (Bachelor of Arts (B.A.), Biology & Psychology, cum laude with honors)
Professional Experience
+ Founder and Principal, Ergenzinger IP Law
+ Chief Legal Officer and Senior VP of Innovation, Lexaria Bioscience Corp.
+ Partner, FisherBroyles, LLP
+ Counsel and Life Sciences Patent Attorney, Olive Law Group, PLLC
+ Counsel and Life Sciences Practice Group Leader, Ward and Smith, PA
+ Director of IP & Legal Affairs, Duke Human Vaccine Institute
+ Associate, Alston & Bird LLP
Notable Achievements
+ Managed worldwide patent portfolio for Prevnar 13® at Wyeth Vaccines
+ Managed $50M/year in IP assets at Duke Human Vaccine Institute
+ Business North Carolina's "Legal Elite" for Intellectual Property (2015)
+ National Institute of Mental Health Predoctoral Fellowship (1997-1999)
+ Co-Founder and Editor in Chief of Wake Forest Intellectual Property Law Journal
Publications & Speaking Engagements
+ Author and co-author of over 100 scientific and legal publications
+ Published in Nature Neuroscience, Nature Biotechnology, Stanford Technology Law Review
+ Adjunct professor at Wake Forest, UNC, and Campbell law schools
+ Invited speaker for NC Bar Association, BIO, Southeast BIO, and various universities
Professional Affiliations
+ NC Bar Association: Co-Chair of Biotech/Chemical Patent Committee (2014-2018)
+ Biotechnology Industry Organization (BIO): Member of IP Counsel's Committee (2003-2009)
+ Southeast BIO: Member of Board of Directors (2006-2009)
+ Beta Beta Beta Biological Honor Society
+ Psi Chi Psychological Honor Society